Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Dyax and Abgenix seek novel antibody technology

Jan. 15, 2001

No Comments

Cephalon and R.W. Johnson to collaborate on protein kinase inhibitors

Jan. 15, 2001

No Comments

Abgenix further extends antibody collaborations with Pfizer, Amgen

Jan. 12, 2001

No Comments

Medarex and Novo Nordisk codevelop antibodies with broad therapeutic applications

Jan. 11, 2001

No Comments

Potent new nonpeptide ORL1 receptor agonist discovered at Novo Nordisk

Jan. 9, 2001

No Comments

Oxford BioMedica develops Lentivector transport technology with neurological applications

Jan. 9, 2001

No Comments

Aurora and R.W. Johnson expand ion channel technology agreement

Jan. 9, 2001

No Comments

Lexicon Genetics and Abgenix establish drug target validation collaboration

Jan. 8, 2001

No Comments

Antibody research at Lilly to be accelerated using Trans-Phase Technology

Jan. 5, 2001

No Comments

Antibody-based therapeutics sought under MorphoSys-Biogen collaboration

Jan. 4, 2001

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies
RSS

Dyax and Abgenix seek novel antibody technology

Cephalon and R.W. Johnson to collaborate on protein kinase inhibitors

Abgenix further extends antibody collaborations with Pfizer, Amgen

Medarex and Novo Nordisk codevelop antibodies with broad therapeutic applications

Potent new nonpeptide ORL1 receptor agonist discovered at Novo Nordisk

Oxford BioMedica develops Lentivector transport technology with neurological applications

Aurora and R.W. Johnson expand ion channel technology agreement

Lexicon Genetics and Abgenix establish drug target validation collaboration

Antibody research at Lilly to be accelerated using Trans-Phase Technology

Antibody-based therapeutics sought under MorphoSys-Biogen collaboration

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies RSS

Drug design, drug delivery and technologies
RSS